Physician profile
Saad Iqbal
NPI 1548589674
$1,618.44
in general payments reported to CMS, 2019-2025
11 companies · $678 in 2025
The $678 reported for 2025 was more than what 82% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $184 · 2021: $194 · 2022: $136 · 2023: $267 · 2024: $160 · 2025: $678.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,105.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,105.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $363.97 | 2025 | Alphavac |
| Sirtex Medical INC | $305.47 | 2022-2025 | Sir-Spheres Microspheres, Lava Les (Liquid Embolic System) |
| Balt USA, LLC | $244.49 | 2023 | Prestige Coil System |
| Stryker Corporation | $181.61 | 2025 | Flowtriever, Optablate |
| Inari Medical, INC. | $122.57 | 2021 | |
| Penumbra, INC. | $97.32 | 2024 | Ruby Coil |
| Bard Peripheral Vascular, INC. | $83.00 | 2019 | |
| Terumo Medical Corporation | $83.00 | 2019 | |
| Siemens Medical Solutions USA, INC. | $71.00 | 2021 | |
| Telix Pharmaceuticals | $48.28 | 2023-2024 | Illuccix |
| Medtronic USA, INC. | $17.73 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Saad Iqbal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.